- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about TAK
Recent news which mentions TAK
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
Takeda Discontinues Two Mid-Stage Narcolepsy Trials
October 06, 2021
From Benzinga
Why Novavax Sank by Nearly 5% on Tuesday
October 05, 2021
From Motley Fool
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
October 03, 2021
From Benzinga
This Healthcare Company Is Using AI to Develop Drugs
October 03, 2021
From Motley Fool
From Benzinga
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
Takeda In-Licenses Hunter Syndrome Candidate
September 30, 2021
From Benzinga
3 Biotech Stocks Wall Street Thinks Could Rise 44% or Better
September 30, 2021
From Motley Fool
Takeda Guilty Of Supply Contract Breach With AbbVie For Prostate Cancer Drug
September 24, 2021
From Benzinga
9 Health Care Stocks Showing Unusual Options Activity In Today's Session
September 21, 2021
From Benzinga
Mirum, Takeda Ink Maralixibat Licensing Pact In Japan
September 21, 2021
From Benzinga
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
September 19, 2021
From Benzinga
From Benzinga
Takeda's Exkivity Scores FDA Nod As First Oral Therapy For Lung Cancer With EGFR Exon20 Insertion
September 16, 2021
From Benzinga
Novavax Has More Room to Run as the Vaccination Push Carries On
September 14, 2021
From InvestorPlace
ADHD Drug Developer Cingulate Plans NASDAQ Debut
September 10, 2021
From Benzinga
Why Novavax Stock Is Slipping Again Today
September 10, 2021
From Motley Fool
Novavax Stock Is Best Covid Vaccine Name To Speculate On
September 09, 2021
From InvestorPlace
Why Novavax Stock Surged Today
September 07, 2021
From Motley Fool
NVAX Stock: The Big Reason Why Novavax Shares Are Gaining Today
September 07, 2021
From InvestorPlace
Novavax Shares Surge On Vaccine Supply Deal With Japan
September 07, 2021
From Benzinga
U.S. COVID-19 case tally tops 40 million, and hospitalizations over Labor Day holiday were more than double last year’s
September 07, 2021
From MarketWatch
Novavax Stock Is a Steal Here If You Believe It Will Come Through
September 03, 2021
From InvestorPlace
Takeda's Breakthrough Blood Cancer Drug Flunks In Phase 3 Study
September 02, 2021
From Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
Moderna Japan Scare Might Offer a Small Lift to Still-Alive Novavax Stock
September 02, 2021
From InvestorPlace
Moderna Reviews Contamination In Vaccine Lot Distributed In Japan
September 01, 2021
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.